Financial Market News

Applied Materials guided above forecasts, Washington sued Arkansas to protect prediction markets, and producer prices meet a 5.1% 10-year.

MARKET PULSE

AI's Suppliers Raised Their Forecasts. Money Kept Getting Pricier.

AI's suppliers raised their forecasts on the day Nvidia announced its founder's exit, while bonds kept raising the cost of money for the build. Cerebras (CBRS) raised its full-year outlook and jumped after hours. Nvidia (NVDA) closed at $166.19 and was higher before the bell.

The S&P 500, Nasdaq and Dow each fell about 0.4% on Thursday. Small caps and homebuilders fell about 1.7%, while energy stocks rose 1.5%. Rate-sensitive groups took the heavier losses, a sign that bond yields set Thursday's tone more than Nvidia did.

The 10-year yield closed Thursday at 5.10%. The dollar held near its highest since April 2025. Bitcoin ended Thursday near $71,400, then slipped below $70,000 overnight to its lowest since August.

The International Energy Agency said oil supply has topped demand for the first time since the war in Iran began. Brent settled at $95.82 and barely moved overnight. October producer prices come next.

Investor Signal

Investors now have proof of AI demand and its rising funding bill. That helps companies that pay for growth with their own cash. It hurts those that must borrow to build. A core producer-price reading at or below forecast, with the two-year back under 4.8%, would say the rate shock has peaked.

PREMIER FEATURE

The Ultimate Passive Income Play

The #1 income play for late 2026 is NOT a stock, bond or private company...

Rather, it's a little-known alternative investment that could hand you a double-digit yield from oil.

Find Out What It Is Right Here

AI DEMAND WATCH

Cisco and Applied Guided Above Forecasts. Cisco's Margin Paid Part of the Bill.

Two AI suppliers beyond Nvidia just showed demand still rising, and one showed what it now costs to meet it. Cisco (CSCO) said revenue rose 24% to $18.5 billion, above forecasts. It raised its AI forecast for cloud giants to $9 billion.

Applied Materials (AMAT) posted record revenue of $10.41 billion, up 53%. Its forecast for this quarter, about $11.1 billion, topped estimates. It sees chip-tool spending growing more than 30% in 2027.

Cisco's adjusted gross margin fell to 65.6% from 68.1% a year earlier, as hardware outgrew software and memory costs rose. The shares rose after hours, then gave it back and more premarket.

Investor Signal

The AI debate has moved from demand to margins. Suppliers are selling more. But parts costs take a bigger cut, and a beat that fades by morning suggests sales growth alone no longer clears the bar. If Cisco's adjusted margin falls below 65% this quarter, costs are winning.

NVIDIA WATCH

Four Brokers Cut Nvidia. Its Former Chief Agreed to Testify.

Nvidia's problem has moved to Washington, where no board can fix it. House Foreign Affairs Chairman Brian Mast said Jensen Huang agreed to testify to lawmakers behind closed doors after they threatened a subpoena. No date is set. Both parties in Congress want tighter limits on chip sales to China. Some want them in the defense bill.

Bernstein cut Nvidia (NVDA) and halved its target to $200. Oppenheimer and Melius cut too. William Blair cut Nvidia but raised AMD (AMD) to outperform, which suggests brokers see a company problem more than a chip problem.

Nvidia closed at $166.19 on Thursday. Its results arrive Tuesday, the first under interim chief Colette Kress. The suppliers' results suggest demand is holding. That ties Nvidia's discount to its own risks.

Investor Signal

Investors see the leadership change as a discount a search can fix. Export limits are a harder risk because they can cap sales that no new chief can restore. That makes Washington the bigger swing factor for the stock. A defense-bill export curb could turn the discount into lost sales.

FROM OUR PARTNERS

The REAL Reason Trump Is Invading Iran

For a moment…

Forget about Trump’s ties to Israel.

Forget about reports of Iran’s nuclear program.

Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.

Click here to find out what it is.

If you have even a single dollar invested in the U.S. stock market, this is going to directly impact you.

Discover the reason here.

AI FUNDING WATCH

OpenAI Reportedly Raised Half Its Ask at a $1.25 Trillion Price.

OpenAI found buyers at its price, but not enough of them. It raised $15 billion at a $1.25 trillion value, CNBC reported, against a goal of up to $30 billion. The round has not formally closed.

Rounds that fall short usually cut the price. This one cut the size instead. That matters beyond OpenAI, because a held price props up the private marks of AI firms valued against it. Private money capped its bet in a week of strong AI demand.

Investor Signal

The held price protects private AI values for now. But capital is now the scarcer input at the top. If the formal close adds money above $15 billion at the same price, the shortfall was timing. A cheaper next round would show the price giving way.

RATES WATCH

Two-Year Yields Jumped in Two Sessions. Producer Prices Test the Move.

Short-term rates may be doing part of the Fed's job already. The two-year yield rose to 4.86% Thursday from 4.56% Monday, and futures already price a longer run of hikes.

Fed officials still lean toward more hikes. Some are in less of a hurry. San Francisco Fed President Mary Daly called higher yields "most welcome," saying they buy time for "calibrated decisions." New York Fed President John Williams said inflation is "far too high."

October producer prices are forecast to rise 0.4%, with core up 0.3%. The headline jumped 1.3% in September. The yen briefly passed 160 per dollar on Fed hike bets. Each step up in short-term rates raises borrowing costs for small firms, home buyers and the AI builders that borrow to expand.

Investor Signal

The Fed is debating pace, while bonds already price a longer cycle. That keeps pressure on borrowers and on stocks valued for distant profits. If core producer prices rise 0.4% or more, the case for a half-point hike in December gets stronger. A softer core reading would back Daly's view.

PARTNER SPOTLIGHT

AI CEO Issues Code Red: Prepare for Meltdown

The CEO of this AI company (click here to get the name, 100% free) just issued a CODE RED in an internal memo…

Warning his employees that they’re dealing with a critical situation.

Another company executive even implied they might need a government bailout.

And now Jim Rickards is predicting this company is about to go bust, in a full-blown AI meltdown that could be 10 times bigger than Lehman Brothers.

Click here to see the details and learn how to prepare.

KALSHI WATCH

Washington Sued a State to Protect Prediction Markets. A Louisiana Judge Ordered Them Out.

The fight over prediction markets is now federal against state, and the result sets how big these venues can grow. The Justice Department and futures regulator sued Arkansas's attorney general, reports said. They argue federal law gives the regulator sole say over event contracts.

Louisiana moved the other way. A state judge temporarily barred Kalshi, Polymarket, Robinhood (HOOD), Coinbase (COIN) and others from offering event contracts there, according to a copy the attorney general posted. The order lapses in 10 days unless the court extends it. Kalshi is reportedly in talks to raise at a $65 billion value.

Investor Signal

Federal backing raises the odds of one national market for event contracts. That supports venue values and the brokers that sell the contracts. Until a court rules, each state order shrinks the market. If Louisiana's order is extended or a federal judge in Arkansas refuses an injunction, the state-by-state model gains ground.

CLOSING LENS

This week's reports from AI's suppliers settled the demand question for now. They did not settle the price of everything around it. Memory costs ate into a margin. Private money filled only half an order. Short-term yields kept climbing, and Washington turned a leadership change into a fight over policy. Demand is still the engine, but the cost of money, parts and permission is now the brake. Producer prices are the next reading on how hard it presses.

Big Pharma Stopped Watching AI Drug Discovery. It Started Paying.

Sanofi has paid one AI biotech $144 million in upfront and milestone payments. Eli Lilly invested $40 million in another. Bristol Myers Squibb is putting a third company's AI co-scientist to work inside its own research organization.
The industry's biggest drugmakers used to watch this technology from the sidelines. Now they're customers.
We profiled the 5 companies leading AI drug development in a new FREE Special Report: AI Moves Into the Biotech Lab.
We'll text it straight to your phone.

Get the Free Report by Text →